Monday November 30, 2020 21:00

Heathcare Press Release : 29 Oct 2020

CStone and LegoChem Biosciences Enter Global Licensing Agreement for New Antibody Drug Heathcare—29 Oct 20

- CStone to acquire exclusive rights for development and commercialization outside South Korea for LCB71, an ROR1 antibody drug conjugate - Agreement adds to CStone's pipeline a potential first-in-class/best-in-class drug candidate with monotherapy and

MMI SpA Launches Breakthrough Technology, Advancing Robotic Microsurgery with the World's Smallest Heathcare—29 Oct 20

MMI SpA, an Italian company dedicated to improving clinical outcomes for patients undergoing microsurgery, announced today the CE Mark, launch and first human use of its Symani(R) Surgical System in Europe for open microsurgical procedures. The first

BioInvent Completes First Licensing Agreement in Greater China, Advised by MSQ Heathcare—29 Oct 20

M.S.Q. Ventures ("MSQ") announced today that its client, BioInvent International, AB ("BioInvent"), has successfully entered into a licensing agreement with CASI Pharmaceuticals, Inc. ("CASI") for the development and commercialization of BI-1206 in the